16.03.2017 • News

Kreimeyer to Lead K+S Supervisory Board

(c) BASF

Andreas Kreimeyer has been proposed to succeed Ralf Bethke as chairman of the supervisory board of German minerals specialist K+S following the company’s annual general meeting (agm) in May. Bethke has served as chairman of the supervisory board since 2007, and prior to that was chairman of the managing board and CEO from 1991.

Kreimeyer, until 2015 a member of the BASF managing board with responsibility for R&D, took a seat on the K+S board the same year.

Thomas Kölbl, chief financial officer of German sugar producer Südzucker has been proposed for a seat on the K+S supervisory board following the agm. The other seats will remain unchanged

Article

The State of the US Specialty Chemicals Industry

Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Book

Innovation Management in Sustainable Chemistry

Innovation Management in Sustainable Chemistry

Comprehensive resource on sustainable chemistry, bridging the skill gap between academic science education and innovation and entrepreneurship

Top-Feature

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Predictive Simulation in Pharma Production

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

When Every Temperature Change Determines the Process

most read

News • Chemistry

CHEManager International Media Kit

Compelling solutions through strategic partnerships

Novo Nordisk to Cut 9,000 Jobs Globally in Major Restructuring

Novo Nordisk announced a global workforce reduction of approximately 9,000 positions to streamline operations and reinvest DKK 8 billion (€1 billion) in growth opportunities for diabetes and obesity treatments.

News • Chemistry

Jens Birgersson Becomes New Brenntag CEO

Jens Birgersson becomes new Brenntag CEO

News • Chemistry

Dow to Shut Down Three Upstream European Assets

Building on the April 2025 announcement, Dow will take actions across its three operating segments to support European profitability, resulting in the closure of sites in Germany and the UK.

News • Bioprocessing

Merck Acquires Chromatography Business from JSR Life Sciences

Merck to acquire the chromatography business of JSR Life Sciences, a leading provider of CDMO services, preclinical and translational clinical research, and bioprocessing solutions.